Estrogen Receptor Modulators
Enclomiphene
Late-stage human trialsInvestigational
Last reviewed: 2026-11-19
Evidence status & limitations
Human trials investigated endocrine outcomes, but approval of clomiphene does not constitute approval of enclomiphene.
Regulatory status
No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Visual symptoms, headache and endocrine changes are concerns; longer-term comparative safety remains uncertain.
Key sources
Identity and editorial screen completed November 19, 2026. A complete primary-source review is pending; literature-search links are labeled explicitly.